Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12636158rdf:typepubmed:Citationlld:pubmed
pubmed-article:12636158lifeskim:mentionsumls-concept:C0033262lld:lifeskim
pubmed-article:12636158lifeskim:mentionsumls-concept:C0003030lld:lifeskim
pubmed-article:12636158lifeskim:mentionsumls-concept:C0003211lld:lifeskim
pubmed-article:12636158pubmed:issue2lld:pubmed
pubmed-article:12636158pubmed:dateCreated2003-3-14lld:pubmed
pubmed-article:12636158pubmed:abstractTextThe objective of this study was to synthesize anhydride prodrugs for prolong action to shield the carboxylic acid group from irritative effects and to temporary hydrophobize the drug so that it becomes accessible to aqueous media when the anhydride residue is hydrolyzed.lld:pubmed
pubmed-article:12636158pubmed:languageenglld:pubmed
pubmed-article:12636158pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12636158pubmed:citationSubsetIMlld:pubmed
pubmed-article:12636158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12636158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12636158pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12636158pubmed:statusMEDLINElld:pubmed
pubmed-article:12636158pubmed:monthFeblld:pubmed
pubmed-article:12636158pubmed:issn0724-8741lld:pubmed
pubmed-article:12636158pubmed:authorpubmed-author:DombAbraham...lld:pubmed
pubmed-article:12636158pubmed:authorpubmed-author:KumarNeerajNlld:pubmed
pubmed-article:12636158pubmed:authorpubmed-author:ShaayaOsnatOlld:pubmed
pubmed-article:12636158pubmed:authorpubmed-author:MagoraAmirAlld:pubmed
pubmed-article:12636158pubmed:authorpubmed-author:SheskinTzviel...lld:pubmed
pubmed-article:12636158pubmed:issnTypePrintlld:pubmed
pubmed-article:12636158pubmed:volume20lld:pubmed
pubmed-article:12636158pubmed:ownerNLMlld:pubmed
pubmed-article:12636158pubmed:authorsCompleteYlld:pubmed
pubmed-article:12636158pubmed:pagination205-11lld:pubmed
pubmed-article:12636158pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:meshHeadingpubmed-meshheading:12636158...lld:pubmed
pubmed-article:12636158pubmed:year2003lld:pubmed
pubmed-article:12636158pubmed:articleTitleAnhydride prodrugs for nonsteroidal anti-inflammatory drugs.lld:pubmed
pubmed-article:12636158pubmed:affiliationDepartment of Medicinal Chemistry and Natural Products, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel 91120.lld:pubmed
pubmed-article:12636158pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12636158pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:12636158pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed